Small for their gestational age, infants account for approximately 10 percent of births, and increased maternal risk for ischemic heart disease in women.

A novel therapy that reduces elevated blood levels of a potentially toxic protein in women with preeclampsia, a dangerous complication of pregnancy, may someday address the therapeutic dilemma posed by the condition – balancing life-threatening risks to the mother with the dangers that early delivery poses to an immature fetus.

Researchers may have identified a promising novel diagnostic biomarker for ectopic pregnancy.

By Gustafsdottir, Sigrun M Wennstrom, Stefan; Fredriksson, Simon; Schallmeiner, Edith; Hamilton, Andrew D; Sebti, Said M; Landegren, Ulf BACKGROUND: Improved methods are required to screen drug candidates for their influences on protein interactions.

LEUVEN, Belgium and LUND, Sweden, January 18 /PRN